Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03127722 · ClinicalTrials.gov registry record · NA
Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 990
- Enrollment target
NCT03127722 is a NA study that has completed, run by Bayer. The registered enrollment target is 990 participants.
The verdict
NCT03127722, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 990 participants
- Enrollment target
Study Summary
This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: * Pelvic and/or lower abdominal pain * Abnormal uterine bleeding * Surgical intervention (including "insert removal" and hysterectomy) * Allergic, hypersensitivity, or autoimmune-like reactions
Interventions
- PROCEDURE Blood draw
- DEVICE ESSURE (BAY1454032)
- PROCEDURE Laparoscopic tubal sterilization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 990 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03127722
The ClinicalTrials.gov registry entry for NCT03127722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 990 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT03127722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03127722 about?
NCT03127722 is a clinical study titled "Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization". This study is designed to assess post-procedural outcomes for women who chose to undergo either hysteroscopic sterilization (Essure®) or laparoscopic tubal sterilization, including: * Pelvic and/or lower abdominal pain * Abnormal uterine bleeding * Surgical intervention (including "insert removal" ...
What is the current status of trial NCT03127722?
This trial is currently completed. It is a NA study. The enrollment target is 990 participants. The study started on 2017-05-03. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT03127722?
The interventions under investigation include: Blood draw (PROCEDURE), ESSURE (BAY1454032) (DEVICE), Laparoscopic tubal sterilization (PROCEDURE).
Who is sponsoring clinical trial NCT03127722?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.